LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $332,919 | +106.8% | 221,946 | +61.3% | 0.00% | 0.0% |
| Q4 2022 | $160,955 | +37.6% | 137,568 | +33.1% | 0.00% | 0.0% |
| Q3 2022 | $117,000 | -17.6% | 103,322 | +14.9% | 0.00% | 0.0% |
| Q2 2022 | $142,000 | -68.4% | 89,960 | -53.0% | 0.00% | -85.7% |
| Q1 2021 | $450,000 | +36.0% | 191,483 | +1.9% | 0.01% | +40.0% |
| Q4 2020 | $331,000 | +263.7% | 187,964 | +94.4% | 0.01% | +400.0% |
| Q3 2020 | $91,000 | -22.9% | 96,704 | -28.4% | 0.00% | -50.0% |
| Q2 2020 | $118,000 | – | 135,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $85,694,000 | 4.37% |
| Defender Capital, LLC. | 4,798,270 | $12,707,000 | 4.13% |
| Raffles Associates | 93,590 | $236,000 | 0.22% |
| Prescott General Partners LLC | 1,851,851 | $4,667,000 | 0.16% |
| DCF Advisers, LLC | 87,000 | $219,000 | 0.10% |
| Laidlaw Wealth Management LLC | 104,841 | $264,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $113,000 | 0.06% |
| Strategic Wealth Investment Group, LLC | 70,625 | $179,000 | 0.05% |
| Fort Sheridan Advisors LLC | 47,931 | $121,000 | 0.04% |
| Sightline Wealth Advisors, LLC | 14,958 | $38,000 | 0.03% |